HEADER IMMUNE SYSTEM 03-OCT-00 1FZO TITLE MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 TITLE 2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-B ALPHA CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: EXTRACELLULAR DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PROTEIN (BETA-2-MICROGLOBULIN); COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: PROTEIN (NUCLEOCAPSID PROTEIN); COMPND 13 CHAIN: P; COMPND 14 FRAGMENT: RESIDUES 324-332; COMPND 15 SYNONYM: SEV9; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 11 ORGANISM_TAXID: 10090; SOURCE 12 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 13 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 OTHER_DETAILS: THE PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 18 OF THE PEPTIDE IS FOUND NATURALLY IN SENDAI VIRUS. KEYWDS MAJOR HISTOCOMPATIBILITY COMPLEX PEPTIDE-MHC, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR M.G.RUDOLPH,J.A.SPEIR,A.BRUNMARK,N.MATTSSON,M.R.JACKSON,P.A.PETERSON, AUTHOR 2 L.TEYTON,I.A.WILSON REVDAT 7 30-OCT-24 1FZO 1 REMARK REVDAT 6 03-NOV-21 1FZO 1 SEQADV HETSYN REVDAT 5 29-JUL-20 1FZO 1 COMPND REMARK SEQADV HETNAM REVDAT 5 2 1 LINK SITE ATOM REVDAT 4 13-JUL-11 1FZO 1 VERSN REVDAT 3 24-FEB-09 1FZO 1 VERSN REVDAT 2 01-APR-03 1FZO 1 JRNL REVDAT 1 28-MAR-01 1FZO 0 JRNL AUTH M.G.RUDOLPH,J.A.SPEIR,A.BRUNMARK,N.MATTSSON,M.R.JACKSON, JRNL AUTH 2 P.A.PETERSON,L.TEYTON,I.A.WILSON JRNL TITL THE CRYSTAL STRUCTURES OF K(BM1) AND K(BM8) REVEAL THAT JRNL TITL 2 SUBTLE CHANGES IN THE PEPTIDE ENVIRONMENT IMPACT JRNL TITL 3 THERMOSTABILITY AND ALLOREACTIVITY. JRNL REF IMMUNITY V. 14 231 2001 JRNL REFN ISSN 1074-7613 JRNL PMID 11290333 JRNL DOI 10.1016/S1074-7613(01)00105-4 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100134178.820 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.5 REMARK 3 NUMBER OF REFLECTIONS : 45593 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.600 REMARK 3 FREE R VALUE TEST SET COUNT : 3473 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 85.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6525 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE : 0.2580 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 558 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.011 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3118 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 352 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.53000 REMARK 3 B22 (A**2) : 1.98000 REMARK 3 B33 (A**2) : -0.44000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.200 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.950 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.570 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.560 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.480 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 48.96 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : LIGAND.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 4 : LIGAND.TOP REMARK 3 TOPOLOGY FILE 5 : ION.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1FZO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-OCT-00. REMARK 100 THE DEPOSITION ID IS D_1000012050. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47714 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 19.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.400 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.8 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.10 REMARK 200 R MERGE FOR SHELL (I) : 0.49400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: CNS, DONE BY RIGID BODY REMARK 200 REFINEMENT OF STARTING MODEL. REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB-ENTRY 2VAA WITHOUT PEPTIDE, WATER, AND MUTATED REMARK 200 SIDE CHAINS TRUNCATED TO ALANINE. REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: K/NA PHOSPHATE, MPD , PH 6.40, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 68.15500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 43.67500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 68.15500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 43.67500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -44.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -127.69 57.06 REMARK 500 GLU A 196 33.59 71.25 REMARK 500 PRO A 210 -177.90 -69.31 REMARK 500 GLN A 226 -72.85 -71.28 REMARK 500 ASP A 227 2.31 -69.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1FZJ RELATED DB: PDB REMARK 900 RELATED ID: 1FZK RELATED DB: PDB REMARK 900 RELATED ID: 1FZM RELATED DB: PDB REMARK 900 RELATED ID: 2VAA RELATED DB: PDB REMARK 900 RELATED ID: 2VAB RELATED DB: PDB DBREF 1FZO A 1 274 UNP P01901 HA1B_MOUSE 22 295 DBREF 1FZO B 1 99 UNP P01887 B2MG_MOUSE 21 119 DBREF 1FZO P 1 9 UNP P04857 NCAP_SENDE 324 332 SEQADV 1FZO PHE A 22 UNP P01901 TYR 43 ENGINEERED MUTATION SEQADV 1FZO ILE A 23 UNP P01901 MET 44 ENGINEERED MUTATION SEQADV 1FZO SER A 24 UNP P01901 GLU 45 ENGINEERED MUTATION SEQADV 1FZO ASN A 30 UNP P01901 ASP 51 ENGINEERED MUTATION SEQADV 1FZO CSO A 121 UNP P01901 CYS 142 MODIFIED RESIDUE SEQRES 1 A 274 GLY PRO HIS SER LEU ARG TYR PHE VAL THR ALA VAL SER SEQRES 2 A 274 ARG PRO GLY LEU GLY GLU PRO ARG PHE ILE SER VAL GLY SEQRES 3 A 274 TYR VAL ASP ASN THR GLU PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 274 ALA GLU ASN PRO ARG TYR GLU PRO ARG ALA ARG TRP MET SEQRES 5 A 274 GLU GLN GLU GLY PRO GLU TYR TRP GLU ARG GLU THR GLN SEQRES 6 A 274 LYS ALA LYS GLY ASN GLU GLN SER PHE ARG VAL ASP LEU SEQRES 7 A 274 ARG THR LEU LEU GLY TYR TYR ASN GLN SER LYS GLY GLY SEQRES 8 A 274 SER HIS THR ILE GLN VAL ILE SER GLY CYS GLU VAL GLY SEQRES 9 A 274 SER ASP GLY ARG LEU LEU ARG GLY TYR GLN GLN TYR ALA SEQRES 10 A 274 TYR ASP GLY CSO ASP TYR ILE ALA LEU ASN GLU ASP LEU SEQRES 11 A 274 LYS THR TRP THR ALA ALA ASP MET ALA ALA LEU ILE THR SEQRES 12 A 274 LYS HIS LYS TRP GLU GLN ALA GLY GLU ALA GLU ARG LEU SEQRES 13 A 274 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 274 ARG TYR LEU LYS ASN GLY ASN ALA THR LEU LEU ARG THR SEQRES 15 A 274 ASP SER PRO LYS ALA HIS VAL THR HIS HIS SER ARG PRO SEQRES 16 A 274 GLU ASP LYS VAL THR LEU ARG CYS TRP ALA LEU GLY PHE SEQRES 17 A 274 TYR PRO ALA ASP ILE THR LEU THR TRP GLN LEU ASN GLY SEQRES 18 A 274 GLU GLU LEU ILE GLN ASP MET GLU LEU VAL GLU THR ARG SEQRES 19 A 274 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA SER VAL SEQRES 20 A 274 VAL VAL PRO LEU GLY LYS GLU GLN TYR TYR THR CYS HIS SEQRES 21 A 274 VAL TYR HIS GLN GLY LEU PRO GLU PRO LEU THR LEU ARG SEQRES 22 A 274 TRP SEQRES 1 B 99 ILE GLN LYS THR PRO GLN ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO PRO GLU ASN GLY LYS PRO ASN ILE LEU ASN CYS TYR SEQRES 3 B 99 VAL THR GLN PHE HIS PRO PRO HIS ILE GLU ILE GLN MET SEQRES 4 B 99 LEU LYS ASN GLY LYS LYS ILE PRO LYS VAL GLU MET SER SEQRES 5 B 99 ASP MET SER PHE SER LYS ASP TRP SER PHE TYR ILE LEU SEQRES 6 B 99 ALA HIS THR GLU PHE THR PRO THR GLU THR ASP THR TYR SEQRES 7 B 99 ALA CYS ARG VAL LYS HIS ASP SER MET ALA GLU PRO LYS SEQRES 8 B 99 THR VAL TYR TRP ASP ARG ASP MET SEQRES 1 P 9 PHE ALA PRO GLY ASN TYR PRO ALA LEU MODRES 1FZO ASN A 86 ASN GLYCOSYLATION SITE MODRES 1FZO ASN A 176 ASN GLYCOSYLATION SITE MODRES 1FZO CSO A 121 CYS S-HYDROXYCYSTEINE HET CSO A 121 7 HET NAG C 1 14 HET FUL C 2 10 HET NAG A 500 14 HET MRD A 701 8 HET MPD A 702 8 HET PO4 B 802 5 HET MPD B 703 8 HETNAM CSO S-HYDROXYCYSTEINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUL BETA-L-FUCOPYRANOSE HETNAM MRD (4R)-2-METHYLPENTANE-2,4-DIOL HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETNAM PO4 PHOSPHATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUL BETA-L-FUCOSE; 6-DEOXY-BETA-L-GALACTOPYRANOSE; L- HETSYN 2 FUL FUCOSE; FUCOSE; 6-DEOXY-BETA-L-GALACTOSE FORMUL 1 CSO C3 H7 N O3 S FORMUL 4 NAG 2(C8 H15 N O6) FORMUL 4 FUL C6 H12 O5 FORMUL 6 MRD C6 H14 O2 FORMUL 7 MPD 2(C6 H14 O2) FORMUL 8 PO4 O4 P 3- FORMUL 10 HOH *352(H2 O) HELIX 1 1 ALA A 49 GLU A 55 5 7 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 GLY A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 LEU A 180 1 6 HELIX 7 7 LYS A 253 GLN A 255 5 3 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N SER A 24 O PHE A 36 SHEET 4 A 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 A 8 THR A 94 VAL A 103 -1 N ILE A 95 O ALA A 11 SHEET 6 A 8 LEU A 109 TYR A 118 -1 N LEU A 110 O GLU A 102 SHEET 7 A 8 ILE A 124 LEU A 126 -1 O ILE A 124 N TYR A 116 SHEET 8 A 8 TRP A 133 ALA A 135 -1 N THR A 134 O ALA A 125 SHEET 1 B 4 LYS A 186 SER A 193 0 SHEET 2 B 4 LYS A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 B 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 B 4 GLU A 229 LEU A 230 -1 O GLU A 229 N SER A 246 SHEET 1 C 4 LYS A 186 SER A 193 0 SHEET 2 C 4 LYS A 198 PHE A 208 -1 N THR A 200 O HIS A 192 SHEET 3 C 4 PHE A 241 PRO A 250 -1 N PHE A 241 O PHE A 208 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 4 GLU A 222 GLU A 223 0 SHEET 2 D 4 THR A 214 LEU A 219 -1 N LEU A 219 O GLU A 222 SHEET 3 D 4 TYR A 257 TYR A 262 -1 O THR A 258 N GLN A 218 SHEET 4 D 4 LEU A 270 LEU A 272 -1 N LEU A 270 O VAL A 261 SHEET 1 E 4 GLN B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 N ASN B 24 O TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 N PHE B 62 O PHE B 30 SHEET 4 E 4 GLU B 50 PHE B 56 -1 N GLU B 50 O HIS B 67 SHEET 1 F 4 LYS B 44 LYS B 45 0 SHEET 2 F 4 GLU B 36 LYS B 41 -1 N LYS B 41 O LYS B 44 SHEET 3 F 4 TYR B 78 LYS B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 F 4 LYS B 91 TYR B 94 -1 O LYS B 91 N VAL B 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.01 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 LINK ND2 ASN A 86 C1 NAG A 500 1555 1555 1.45 LINK C GLY A 120 N CSO A 121 1555 1555 1.33 LINK C CSO A 121 N ASP A 122 1555 1555 1.33 LINK ND2 ASN A 176 C1 NAG C 1 1555 1555 1.45 LINK O6 NAG C 1 C1 FUL C 2 1555 1555 1.39 CISPEP 1 TYR A 209 PRO A 210 0 -0.19 CISPEP 2 HIS B 31 PRO B 32 0 0.05 CRYST1 136.310 87.350 45.170 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007336 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011448 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022137 0.00000